P20—Agalsidase Beta Treatment is Associated With Improvement in Quality of Life in Patients With Fabry Disease: Findings From the Fabry Registry. - Feldt-Rasmussen, U.; Watt, T.; Burlina, A.P.; Cazzorla, C.; Schönfeld, D.; Banikazemi, M.; Hopkin, R.J.; Martins, A.M.; Sims, K.; Beitner-Johnson, D.; O'Brien, F. (Clinical Therapeutics, 2012)